MedMountain Ventures

Confido Health provides AI-driven solutions that automate healthcare operations, including appointment management and patient follow-ups, by integrating with existing clinical systems to reduce administrative burdens. Its platform uses artificial intelligence to streamline routine tasks and improve communication among staff, patients, and other stakeholders, enabling clinics and surgery centers to operate more efficiently and focus on patient care. The company aims to enhance care quality by cutting unnecessary administrative time and optimizing workflows across care teams.

AvoMD is a no-code software platform that converts clinical content into 'virtual clinical consults', providing instant expert guidance at the bedside. It improves healthcare outcomes while saving clinicians approximately half of their time spent on accessing and using information.

Gradient Health develops an open research platform that provides artificial intelligence–based medical imaging diagnostics and infrastructure. The platform gives access to a clinical sandbox, open-source tooling, and documentation to help developers translate research into an interoperable, secure clinical environment.

Eddii is a digital health platform designed to motivate individuals with diabetes to manage their condition more effectively. It offers a gamified mobile application featuring an engaging virtual character that encourages users to track and record their health data daily, providing weekly reports and rewards for healthy practices.

Epitel is a digital health company developing a wearable, wireless EEG monitoring platform that enables accessible, reliable seizure detection. The system combines a cloud-based wearable sensor network with artificial intelligence to identify electrographic seizures, providing brain health insights for physicians, caregivers, and patients with neurological disorders to improve quality of life and care.

Options MD is a telemedicine platform that employs AI-driven algorithms to match individuals with severe or treatment-resistant mental illnesses to personalized care options. It then connects these patients with in-house psychiatric experts for appropriate medical assistance.

Options MD is a telemedicine platform that employs AI-driven algorithms to match individuals with severe or treatment-resistant mental illnesses to personalized care options. It then connects these patients with in-house psychiatric experts for appropriate medical assistance.

Inherent Biosciences is a molecular diagnostics company focused on transforming the traditional trial and error approach in medicine. The company leverages its innovative epigenetic medicine platform to address various health challenges by identifying gene dysregulation and its associated pathways. By translating biological insights into actionable information, Inherent Biosciences aims to enhance treatment strategies for conditions such as pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, and COVID-19. This approach not only guides healthcare professionals in managing complex diseases but also seeks to provide personalized insights that empower patients in their health journeys.